ArticlePakistan journal of medical sciences2026
Dietary flavonoid intake is linked to reduced all-cause mortality: Findings from the National Health and Nutrition Examination Survey (NHANES).
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To examine the relationship between dietary flavonoid consumption and all-cause mortality (ACM) among U.S. adults, and determine the optimal intake levels and target populations that could benefit from such dietary interventions. Methodology: A cohort study employing data from the National Health and Nutrition Examination Survey (NHANES) was used with follow-up for ACM status until December 31, 2018. This was a United States population-based study employing NHANES data. A total of 4,60 adults from NHANES were asked about their dietary flavonoid intake via 24 hours dietary recall. Results: After a median follow-up of 121 months, 51 mortality cases were recorded. Analysis found a U-shaped correlation between dietary flavonoid consumption and ACM, with optimal intake levels ranging from 48.93 mg to 735.65 mg. Subgroup analysis revealed that males (P = 0.024), smokers (P = 0.010), non-drinkers (P = 0.025), and individuals without obesity (P = 0.003) and cardiovascular disease (P = 0.008) benefited the most from the dietary flavonoid intake. Conclusions: Optimal dietary flavonoid intake is linked to reduced ACM, especially in males, smokers, non-drinkers, and individuals without obesity or cardiovascular disease. These findings show that personalized dietary recommendations may be important for improving health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.